Retroviral BAX gene transfer fails to sensitize malignant glioma cells to CD95L-induced apoptosis and cancer chemotherapy

Int J Cancer. 1998 Aug 12;77(4):645-8. doi: 10.1002/(sici)1097-0215(19980812)77:4<645::aid-ijc27>3.0.co;2-3.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology
  • Apoptosis
  • Fas Ligand Protein
  • Gene Transfer Techniques*
  • Genetic Vectors / genetics*
  • Glioma / genetics*
  • Glioma / metabolism
  • Glioma / therapy
  • Humans
  • Ligands
  • Membrane Glycoproteins / pharmacology
  • Mice
  • Neoplasm Proteins / metabolism
  • Proto-Oncogene Proteins / genetics*
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2*
  • Retroviridae / genetics*
  • bcl-2-Associated X Protein

Substances

  • Antineoplastic Agents
  • BAX protein, human
  • Bax protein, mouse
  • FASLG protein, human
  • Fas Ligand Protein
  • Fasl protein, mouse
  • Ligands
  • Membrane Glycoproteins
  • Neoplasm Proteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-2-Associated X Protein